Clincosm LogoSign in Get a demo

Lymphoma, Large-cell, Anaplastic

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,

Not yet recruiting
  • Mycosis Fungoides of Skin (Diagnosis)
  • +5 more
  • Med-Jet Injector
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023

Patterns and Disease Control in cHL and sALCL in Routine

Completed
  • Hodgkin Disease
  • Lymphoma, Large-cell, Anaplastic
    • Astrakhan, Russian Federation
    • +49 more
    Dec 19, 2022

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022

    Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

    Terminated
    • Neoplasms
    • +27 more
    • Culver City, California
    • +28 more
    Jul 25, 2022

    Lymphoma, Large-Cell, Anaplastic, NSCLC Trial (Brigatinib)

    Completed
    Has Results
    • Lymphoma, Large-Cell, Anaplastic
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Jul 26, 2021

    Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic Trial in China (Brentuximab Vedotin)

    Completed
    Has Results
    • Hodgkin Disease
    • Lymphoma, Large-Cell, Anaplastic
    • Brentuximab Vedotin
    • Beijing, Beijing, China
    • +6 more
    Feb 3, 2021

    Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

    No longer available
    • Disease, Hodgkin
    • +3 more
    • brentuximab vedotin
    • Stanford, California
    • +30 more
    Sep 17, 2020

    Lymphoma, Large-Cell, Anaplastic, Lymphoma, NK-cell, Lymphoma, T-cell Trial in United Kingdom, United States (brentuximab

    Completed
    • Lymphoma, Large-Cell, Anaplastic
    • +2 more
    • brentuximab vedotin
    • +4 more
    • Birmingham, Alabama
    • +10 more
    Jun 27, 2017

    Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

    Completed
    Has Results
    • Lymphoma, Large-Cell, Anaplastic
    • Lymphoma, Non-Hodgkin
    • brentuximab vedotin
    • Birmingham, Alabama
    • +21 more
    Feb 2, 2017

    Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in France, United States (brentuximab vedotin)

    Completed
    Has Results
    • Disease, Hodgkin
    • +2 more
    • brentuximab vedotin
    • Birmingham, Alabama
    • +16 more
    Dec 7, 2016

    Carcinomas, Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic Trial in United States (brentuximab vedotin, rifampin, midazolam)

    Completed
    • Carcinomas
    • +4 more
    • brentuximab vedotin
    • +3 more
    • Duarte, California
    • +5 more
    Dec 17, 2014

    Lymphoma, Non-Hodgkin, Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic Trial in United States (SGN-35)

    Completed
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Birmingham, Alabama
    • +3 more
    Dec 17, 2014

    Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in United States (SGN-35, gemcitabine)

    Terminated
    • Disease, Hodgkin
    • +2 more
    • Birmingham, Alabama
    • +4 more
    Dec 17, 2014

    Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Germany, United States (brentuximab vedotin)

    Completed
    • Disease, Hodgkin
    • +2 more
    • brentuximab vedotin
    • Birmingham, Alabama
    • +8 more
    Dec 11, 2014